PCH
Polar Capital Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.4M | Sell |
237,500
-42,500
| -15% | -$13.9M | 0.41% | 67 |
|
|
2025
Q1 | $75.6M | Sell |
280,000
-30,000
| -10% | -$8.1M | 0.46% | 65 |
|
|
2024
Q4 | $72.9M | Hold |
310,000
| – | – | 0.41% | 63 |
|
|
2024
Q3 | $85.3M | Buy |
310,000
+25,000
| +9% | +$6.88M | 0.41% | 55 |
|
|
2024
Q2 | $69.3M | Buy |
285,000
+50,000
| +21% | +$12.2M | 0.41% | 68 |
|
|
2024
Q1 | $35.1M | Buy |
235,000
+50,000
| +27% | +$7.47M | 0.18% | 106 |
|
|
2023
Q4 | $35.4M | Sell |
185,000
-50,000
| -21% | -$9.57M | 0.22% | 100 |
|
|
2023
Q3 | $41.6M | Hold |
235,000
| – | – | 0.31% | 84 |
|
|
2023
Q2 | $44.6M | Sell |
235,000
-76,918
| -25% | -$14.6M | 0.23% | 90 |
|
|
2023
Q1 | $62.5M | Buy |
311,918
+14,418
| +5% | +$2.89M | 0.41% | 70 |
|
|
2022
Q4 | $70.7M | Buy |
297,500
+182,500
| +159% | +$43.4M | 0.56% | 53 |
|
|
2022
Q3 | $23K | Sell |
115,000
-98,079
| -46% | -$19.6K | 0.15% | 132 |
|
|
2022
Q2 | $31.1K | Sell |
213,079
-16,754
| -7% | -$2.44K | 0.18% | 110 |
|
|
2022
Q1 | $37.5K | Sell |
229,833
-305,798
| -57% | -$49.9K | 0.17% | 109 |
|
|
2021
Q4 | $90.8K | Buy |
535,631
+11,919
| +2% | +$2.02K | 0.34% | 59 |
|
|
2021
Q3 | $98.9K | Buy |
523,712
+195,430
| +60% | +$36.9K | 0.4% | 50 |
|
|
2021
Q2 | $55.7K | Buy |
328,282
+129,782
| +65% | +$22K | 0.24% | 95 |
|
|
2021
Q1 | $28M | Sell |
198,500
-3,500
| -2% | -$494K | 0.17% | 130 |
|
|
2020
Q4 | $26.3M | Buy |
+202,000
| New | +$26.3M | 0.16% | 130 |
|